Enzychem Lifesciences (XKRX:183490) Construction In Progress : ₩89 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Enzychem Lifesciences Construction In Progress?

Enzychem Lifesciences's quarterly construction in progress stayed the same from Sep. 2024 (₩89 Mil) to Dec. 2024 (₩89 Mil) and stayed the same from Dec. 2024 (₩89 Mil) to Mar. 2025 (₩89 Mil).

Enzychem Lifesciences's annual construction in progress increased from Dec. 2022 (₩69 Mil) to Dec. 2023 (₩123 Mil) but then declined from Dec. 2023 (₩123 Mil) to Dec. 2024 (₩89 Mil).

Enzychem Lifesciences Construction In Progress Historical Data

The historical data trend for Enzychem Lifesciences's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzychem Lifesciences Construction In Progress Chart

Enzychem Lifesciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

559.02

194.46

68.50

122.75

89.00

Enzychem Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Construction In Progress	Get a 7-Day Free Trial															89.00	89.00	89.00	89.00	89.00

Enzychem Lifesciences Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Enzychem Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzychem Lifesciences Corp (XKRX:183490) » Definitions » Construction In Progress

Traded in Other Exchanges

N/A

Address

27 Gangnamdae-ro Seocho-gu, 10th Floor, aT Center, Seoul, KOR, 135-280

Website

http://www.enzychem.com

Enzychem Lifesciences Corp develops and produces APIs and functional health foods. It manufactures veterinary medicine tablets, capsules, syrups, injections, ointments, solutions for the diagnosis and prevention of various diseases. The company is also developing drugs to treat chemotherapy-induced neutropenia, chemo-radiation therapy-induced oral mucositis, asthma, psoriasis, rheumatoid arthritis, and others.

Enzychem Lifesciences Headlines

No Headlines